Back
Range Cancer Therapeutics ETF Vs. Fundamental Global Industry Stock Comparison
Sell
7
CNCR
Range Cancer Therapeutics ETF
Last Price:
$11.00
Seasonality Move:
-3.32%
Sell
24
FGF
Fundamental Global
Last Price:
$18.90
Seasonality Move:
5.74%
Sell
7
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
-
The current Range Cancer Therapeutics ETF [CNCR] share price is $10.83. The Score for CNCR is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
-
CNCR is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
24
Fundamental Global (FGF)
is a Sell
Is Fundamental Global a Buy, Sell or Hold?
-
The current Fundamental Global [FGF] share price is $18.53. The Score for FGF is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
FGF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $10.83Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
FGF Stock Price Chart
What is Fundamental Global's stock price today?
-
The Fundamental Global share price today is $18.53Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FGF is experiencing slight selling pressure.
CNCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.4 | Sell |
Relative Strength Index (14 RSI): | 36.15 | Sell |
Chaikin Money Flow: | 2685 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.24 - 12.56) | Sell |
Bollinger Bands (100): | (11.84 - 14.56) | Sell |
FGF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.6 | Sell |
Relative Strength Index (14 RSI): | 36.97 | Sell |
Chaikin Money Flow: | -2926 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.99 - 21.69) | Sell |
Bollinger Bands (100): | (18.79 - 28.13) | Sell |
CNCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.04 | Sell |
20-day SMA: | 11.78 | Sell |
50-day SMA: | 12.09 | Sell |
200-day SMA: | 13.91 | Sell |
8-day EMA: | 11.15 | Sell |
20-day EMA: | 11.58 | Sell |
50-day EMA: | 12.17 | Sell |
200-day EMA: | 13.46 | Sell |
FGF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.03 | Sell |
20-day SMA: | 20.7 | Sell |
50-day SMA: | 21.14 | Sell |
200-day SMA: | 24.47 | Sell |
8-day EMA: | 19.93 | Sell |
20-day EMA: | 20.53 | Sell |
50-day EMA: | 21.64 | Sell |
200-day EMA: | 25.36 | Sell |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Fundamental Global Earnings Growth & FGF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Range Cancer Therapeutics ETF Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Fundamental Global Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |